Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Oil prices surge while gold and silver prices plunge

Oil prices surge while gold and silver prices plunge

智通财经智通财经2026/10/24 01:06
Show original
Due to heightened tensions in the Middle East and market concerns about disruptions in crude oil supply, international oil prices saw a significant increase on the 23rd. Brent crude oil futures prices reached a nearly six-month high. At the close of trading that day, the price of light crude oil futures for December delivery on the New York Mercantile Exchange settled at $103.27 per barrel, up 3.82%; December delivery London Brent crude oil futures closed at $116.72 per barrel, an increase of 3.14%.On the 23rd, rising energy prices triggered concerns about inflation, reinforced expectations of a Federal Reserve rate hike, and, coupled with a stronger dollar, put downward pressure on international gold and silver prices. By the end of trading that day, gold futures for December delivery on the New York Mercantile Exchange were quoted at $4007.90 per ounce, down 1.29%; silver futures for December delivery were priced at $53.949 per ounce, a decrease of 1.92%. (CCTV Finance)
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Amgen (AMGN.US) and AstraZeneca (AZN.US) combination therapy extends small cell lung cancer survival by eight months, reduces risk of death by 58%

Researchers combined Amgen's Imdelltra with AstraZeneca's Imfinzi and found that for patients with aggressive lung cancer whose tumors had already spread, this combination extended survival by about eight months compared to Imfinzi monotherapy. Small cell lung cancer is one of the cancer types with the worst prognosis.

智通财经•2026/10/25 02:56
Amgen (AMGN.US) and AstraZeneca (AZN.US) combination therapy extends small cell lung cancer survival by eight months, reduces risk of death by 58%